Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Double-Blinded, Multi-Center Pivotal Trial of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears

NCT03752827 is registered in ClinicalTrials.gov with InGeneron, Inc. as lead sponsor.

NCT NCT03752827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03752827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Double-Blinded, Multi-Center Pivotal Trial of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears
Lead sponsor
InGeneron, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 13, 2019
Completion date
December 31, 2025
Enrollment
168 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

rotator cuff tear, rotator cuff tendinitis